In the BioHarmony Drug Report Database

"Preview" Icon

Desmopressin

Concentraid, Ddavp, Desmopressin Acetate, Minirin, Nocdurna, Noctiva, Stimate (desmopressin) is a protein pharmaceutical. Desmopressin was first approved as Concentraid on 1982-01-01. It is used to treat enuresis, hemorrhage, neurogenic diabetes insipidus, thrombocytopenia, and von willebrand diseases in the USA. It is known to target vasopressin V1b receptor, vasopressin V2 receptor, vasopressin V1a receptor, and oxytocin receptor. Ddavp’s patents are valid until 2030-06-15 (FDA).

 

Trade Name

 

Concentraid, Ddavp, Desmopressin Acetate, Minirin, Nocdurna, Noctiva, Stimate
 

Common Name

 

desmopressin
 

ChEMBL ID

 

CHEMBL1429
 

Indication

 

enuresis, hemorrhage, neurogenic diabetes insipidus, thrombocytopenia, von willebrand diseases
 

Drug Class

 

Vasoconstrictors (vasopressin derivatives)

Image (chem structure or protein)

Desmopressin structure rendering